医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
3-吲哚丙烯酸 | indole-3-acrylic acid | 1204-06-4 | C11H9NO2 |
|
3-吡嗪羧酰胺 1-氧化物 | 2-pyrazinecarboxamide-4-oxide | 768-36-5 | C5H5N3O2 |
|
3-吡啶醛肟 | 3-pyridinealdoxime | 1193-92-6 | C6H6N2O |
|
3-吡啶磺酸 | 3-pyridinesulfonic acid | 636-73-7 | C5H5NO3S |
|
3-吡啶硼酸 | 3-pyridylboronic acid | 1692-25-7 | C5H6BNO2 |
|
3-吡啶甲醇氮氧化物 | 3-pyridylcarbinol-N-oxide | 6968-72-5 | C6H7NO2 |
|
3-吡啶甲酸酐 | nicotinic anhydride | 16837-38-0 | C12H8N2O3 |
|
3-吡啶氧基乙酸 | (Pyridin-3-yloxy)-acetic acid | 86649-57-2 | C7H7NO3 |
|
3-吡啶基羟基甲烷磺酸 | hydroxy-[3]pyridyl-methanesulfonic acid | 4812-14-0 | C6H7NO4S |
|
3-吡啶基偕胺肟 | nicotinamide oxime | 1594-58-7 | C6H7N3O |
|
3-吡啶基(2-硫酮-3-噻唑烷基)甲酮 | 3-(3-pyridinylcarbonyl)-1,3-thiazolidine-2-thione | 367906-48-7 | C9H8N2OS2 |
|
3-吡啶乙酸乙酯 | ETHYL 3-PYRIDYLACETATE | 39931-77-6 | C9H11NO2 |
|
3-吡啶乙酰腈,a-羟基- | 2-hydroxy-2-(pyridin-3-yl)acetonitrile | 17604-74-9 | C7H6N2O |
|
3-吡啶乙腈 | 3-pyridinylacetonitrile | 6443-85-2 | C7H6N2 |
|
3-吡啶丙醇 | 3-(3-pyridyl)propan-1-ol | 2859-67-8 | C8H11NO |
|
3-吡啶-4-基苯胺 | 3-(pyridin-4-yl)benzenamine | 40034-44-4 | C11H10N2 |
|
3-吡啶-2-基丙酸甲酯 | methyl 3-(pyridin-2-yl)propanoate | 28819-26-3 | C9H11NO2 |
|
3-吡唑甲酸乙酯 | ethyl 1H-pyrazole-3-carboxylate | 5932-27-4 | C6H8N2O2 |
|
3-吡唑-1-苯胺 | 3-(1H-pyrazol-1-yl)aniline | 184097-88-9 | C9H9N3 |
|
3-吡咯烷甲酸甲酯 | methyl pyrrolidine-3-carboxylate | 98548-90-4 | C6H11NO2 |
|
3-吡咯烷-2-喹啉 | 3-Pyrrolidin-2-yl-quinoline | 499207-38-4 | C13H14N2 |
|
3-吡咯烷-1-甲酸苄酯 | 1-carboxybenzyl-3-pyrrolidine | 31970-04-4 | C12H13NO2 |
|
3-吗啉基苯甲醛 | 3-morpholinobenzaldehyde | 446866-87-1 | C11H13NO2 |
|
3-叠氮基-2-氯吡啶 | 3-azido-2-chloropyridine | 102934-51-0 | C5H3ClN4 |
|
3-叔丁硫基-2-氨基吡啶 | 3-(tertbutylthio)pyridin-2-amine | 551950-47-1 | C9H14N2S |
|
3-叔丁氧羰基氨基-4-溴吡啶 | tert-butyl (4-bromopyridin-3-yl)carbamate | 885275-14-9 | C10H13BrN2O2 |
|
3-叔丁氧基羰基氨基-噻吩-2-羧酸甲酯 | methyl 3-((tert-butoxycarbonyl)amino)thiophene-2-carboxylate | 149587-72-4 | C11H15NO4S |
|
3-叔丁氧基-6-氯哒嗪 | 3-chloro-6-t-butoxy-pyridazine | 17321-24-3 | C8H11ClN2O |
|
3-叔丁基磺酰基-2-吡啶甲腈 | 3-(tert-butylthio)picolinonitrile | 178811-40-0 | C10H12N2S |
|
3-叔丁基-1H-吡唑 | 3-tert-butyl-1H-pyrazole | 15802-80-9 | C7H12N2 |
|
3-十四烷基噻吩 | 3-tetradecylthiophene | 110851-66-6 | C18H32S |
|
3-十二烷基噻吩 | 3-dodecylthiophene | 104934-52-3 | C16H28S |
|
3-十一烷基噻吩并[3,2-b]噻吩 | 3-undecylthieno[3,2-b]thiophene | 950223-97-9 | C17H26S2 |
|
3-亚甲基环丁烷羧酸乙酯 | ethyl 3-methylenecyclobutanecarboxylate | 40896-96-6 | C8H12O2 |
|
3-亚甲基环丁基甲腈 | 3-methylenecyclobutanecarbonitrile | 15760-35-7 | C6H7N |
|
3-二苯并噻吩胺 | 3-aminodibenzothiophene | 25288-76-0 | C12H9NS |
|
3-二甲氨基-1-(萘-5-基)丙酮 | 3-(dimethylamino)-1-(1-naphthalenyl)-1-propanone | 10320-49-7 | C15H17NO |
|
3-二甲基氨基甲基-苯并呋喃-2-羧酸 | 3-((dimethylamino)methyl)benzofuran-2-carboxylic acid | 1039892-27-7 | C12H13NO3 |
|
3-二甲基氨基甲基-5-甲基-2-己酮 | 3-[(dimethylamino)methyl]-5-methylhexan-2-one | 91342-74-4 | C10H21NO |
|
3-二甲基-6-溴吡啶 | 6-bromo-2,3-dimethylpyridine | 99132-28-2 | C7H8BrN |
|
3-乙酰氨基香豆素 | 3-acetamidocoumarin | 779-30-6 | C11H9NO3 |
|
3-乙酰氨基邻苯二甲酸二甲酯 | 3-Acetamido-phthalsaeure-dimethylester | 52659-18-4 | C12H13NO5 |
|
3-乙酰氨基茴香硫醚 | N-(3-(methylthio)phenyl)acetamide | 2524-78-9 | C9H11NOS |
|
3-乙酰氨基吡啶 | N-(pyridin-3-yl)acetamide | 5867-45-8 | C7H8N2O |
|
3-乙酰氨基-5-甲基哒嗪 | N-(5-methylpyridazin-3-yl)acetamide | 1314406-52-4 | C7H9N3O |
|
3-乙酰氨基-4-甲基哒嗪 | N-(4-methylpyridazin-3-yl)acetamide | 1314406-37-5 | C7H9N3O |
|
3-乙酰氧基吡啶 | 3-pyridyl acetate | 17747-43-2 | C7H7NO2 |
|
3-乙酰基噻吩 | 1-(thiophen-3-yl)-ethanone | 1468-83-3 | C6H6OS |
|
3-乙酰基喹啉-2(1H)-酮 | 3-acetylquinolin-2(1H)-one | 50290-20-5 | C11H9NO2 |
|
3-乙酰基喹啉 | 1-quinolin-3-yl-ethanone | 33021-53-3 | C11H9NO |
|